Agilent Q2 Revenues Flat, Matching Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent said after the close of the market on Wednesday that its Fiscal Year 2014 second quarter revenues were flat year over year, while its Life Sciences and Diagnostic revenues increased 1 percent.

For the three months ended April 30, Agilent reported total revenues of $1.73 billion, unchanged from a year ago and even with the consensus analyst estimate. Orders in the quarter were up to $1.81 billion from $1.69 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.